Corporate Banner
Satellite Banner
Cell Culture
Scientific Community
Become a Member | Sign in
Home>News>This Article

OZ Biosciences : Capture and Concentrate Virus

Published: Monday, November 19, 2012
Last Updated: Monday, November 19, 2012
Bookmark and Share
OZ Biosciences SAS, specialized in the development of innovative transfection technologies is delighted to announce the launching of new products Mag4C Kits.

Mag4C Kits are specifically developed for capturing, concentrating and storing viruses. These kits are composed of 3 reagents allowing Magnetic Capture/Concentration, Elution and Conservation of viruses.

"We continuously improve our core technology", explains Olivier Zelphati, CEO of OZ Biosciences. Indeed, Mag4C Kits are new specific superparamagnetic nanoparticles formulation evolved from our Magnetofection™ Technology.

Mag4C magnetic nanoparticles capture by electrostatic and hydrophobic interactions viruses in culture medium with 80-99 % efficiency. Simple, rapid and ready to use this product allows concentrating virus by magnetic capture in 30-45 minutes. In this way, ultracentrifugation, precipitation and chemicals are avoided. Once captured onto magnetic beads, viruses can be:

(1) Concentrated and stored with the Conservation Buffer or directly used for cell culture, molecular biology or other assays.

(2) Concentrated, eluted from the magnetic beads with the Elution Buffer and stored with the Conservation Buffer or used for various assays.

Moreover, these kits contain particular conservation buffers that improve virus stability upon storage conditions.

Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,800+ scientific posters on ePosters
  • More than 4,000+ scientific videos on LabTube
  • 35 community eNewsletters

Sign In

Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Scientific News
Novel Tumor Treatment
In the first published results from a $386,000 National Cancer Institute grant awarded earlier this year, a paper by Scott Verbridge and Rafael Davalos has been published.
Personalized Drug Screening for Multiple Myeloma Patients
A personalized method for testing the effectiveness of drugs that treat multiple myeloma may predict quickly and more accurately the best treatments for individual patients with the bone marrow cancer.
Cancer-Fighting Tomato Component Traced
The metabolic pathway associated with lycopene, the bioactive red pigment found in tomatoes, has been traced by researchers at the University of Illinois.
Some Gut Microbes May Be Keystones of Health
University of Oregon scientists have found that strength in numbers doesn’t hold true for microbes in the intestines. A minority population of the right type might hold the key to regulating good health.
The Life Story of Stem Cells
A model analyses the development of stem cell numbers in the human body.
Novel Stem Cell Line Avoids Risk of Introducing Transplanted Tumors
Progenitor cells might eventually be used to repair or rebuild damaged or destroyed organs.
Tissue Engineers Recruit Cells to Make Their Own Strong Matrix
Extracellular matrix is the material that gives tissues their strength and stretch. It’s been hard to make well in the lab, but a Brown University team reports new success. The key was creating a culture environment that guided cells to make ECM themselves.
Towards Patient-Specific Drug Screening
A new breakthrough by the 3D stem cell printing team at Heriot-Watt could pave the way to individually tailored drug testing regimes, both reducing the need for animal testing and ensuring that patients receive drugs which are most effective for their individual needs.
Artificial Kidney Research Gets A Boost
Development of a surgically implantable, artificial kidney — a promising alternative to kidney transplantation or dialysis for people with end-stage kidney disease — has received a $6 million boost.
Improving the Efficiency of Red Blood Cell Production
Study points to way of significantly reducing cost of laboratory-produced cells.

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,800+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,000+ scientific videos